NO20065048L - Kontrastmidler for myocardial perfusjonsbilleddannelse. - Google Patents
Kontrastmidler for myocardial perfusjonsbilleddannelse.Info
- Publication number
- NO20065048L NO20065048L NO20065048A NO20065048A NO20065048L NO 20065048 L NO20065048 L NO 20065048L NO 20065048 A NO20065048 A NO 20065048A NO 20065048 A NO20065048 A NO 20065048A NO 20065048 L NO20065048 L NO 20065048L
- Authority
- NO
- Norway
- Prior art keywords
- myocardial perfusion
- contrast agents
- perfusion imaging
- imaging
- patient
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title abstract 3
- 239000002872 contrast media Substances 0.000 title abstract 2
- 230000002107 myocardial effect Effects 0.000 title abstract 2
- 230000010412 perfusion Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K51/0427—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K51/0419—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K51/0421—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56614604P | 2004-04-28 | 2004-04-28 | |
US11/113,486 US7485283B2 (en) | 2004-04-28 | 2005-04-25 | Contrast agents for myocardial perfusion imaging |
PCT/US2005/014459 WO2005105159A2 (fr) | 2004-04-28 | 2005-04-27 | Agents de contraste pour l'imagerie de perfusion myocardique |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065048L true NO20065048L (no) | 2006-11-03 |
Family
ID=35187299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065048A NO20065048L (no) | 2004-04-28 | 2006-11-03 | Kontrastmidler for myocardial perfusjonsbilleddannelse. |
Country Status (15)
Country | Link |
---|---|
US (3) | US7485283B2 (fr) |
EP (2) | EP2253333B1 (fr) |
JP (1) | JP2007535547A (fr) |
KR (1) | KR101207216B1 (fr) |
CN (1) | CN101843908B (fr) |
AU (1) | AU2005238080B2 (fr) |
BR (1) | BRPI0510487A (fr) |
CA (1) | CA2564737C (fr) |
ES (1) | ES2744544T3 (fr) |
IL (1) | IL178911A (fr) |
MX (1) | MXPA06012299A (fr) |
NO (1) | NO20065048L (fr) |
RU (1) | RU2006141979A (fr) |
SG (1) | SG152254A1 (fr) |
WO (1) | WO2005105159A2 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
JP2006503865A (ja) * | 2002-09-30 | 2006-02-02 | アキュスフィア, インコーポレイテッド | 吸入のための徐放性の多孔性微粒子 |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
CA2533887A1 (fr) * | 2003-09-30 | 2005-04-14 | Acusphere, Inc. | Formulations pharmaceutiques a effet prolonge, administrees par injection, par voie orale ou topique |
US7485283B2 (en) * | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
ES2714900T3 (es) | 2005-06-01 | 2019-05-30 | Bioelectron Tech Corp | Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos |
US7824659B2 (en) * | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
US7913223B2 (en) * | 2005-12-16 | 2011-03-22 | Dialogic Corporation | Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system |
GB0525949D0 (en) | 2005-12-21 | 2006-02-01 | Hammersmith Imanet Ltd | Pet radiotracers |
JP5374162B2 (ja) | 2006-02-22 | 2013-12-25 | エジソン ファーマシューティカルズ, インコーポレイテッド | ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節 |
WO2008133730A2 (fr) * | 2006-11-15 | 2008-11-06 | The Regents Of The University Of California | Analogues de roténone marqués |
CA2967254C (fr) * | 2008-02-29 | 2019-03-26 | Lantheus Medical Imaging, Inc. | Agents de contraste destine aux applications comprenant l'imagerie du cancer |
US8934959B2 (en) * | 2008-07-09 | 2015-01-13 | Koninklijke Philips N.V. | Physiological pharmacokinetic analysis for combined molecular MRI and dynamic PET imaging |
US8314153B2 (en) | 2008-09-10 | 2012-11-20 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
EP2419096B1 (fr) | 2009-04-15 | 2019-11-13 | Lantheus Medical Imaging, Inc. | Stabilisation de compositions radiopharmaceutiques à l'aide d'acide ascorbique |
JP6092628B2 (ja) | 2010-02-08 | 2017-03-08 | ランセウス メディカル イメージング, インコーポレイテッド | 造影剤およびその中間体を合成するための方法および装置 |
SG2014013767A (en) | 2011-09-09 | 2014-05-29 | Lantheus Medical Imaging Inc | Compositions, methods, and systems for the synthesis and use of imaging agents |
AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
CN104771766A (zh) * | 2015-05-07 | 2015-07-15 | 张国明 | 心肌灌注成像的造影剂及制备方法 |
US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
EP3203256A1 (fr) * | 2016-02-02 | 2017-08-09 | B. Braun Melsungen AG | Étalonnage de systèmes d'irm utilisant des concentrations prédéfinies d'isotopes 19f comme référence |
CN106543117B (zh) * | 2016-11-10 | 2019-01-22 | 南京中医药大学 | 具有抗肿瘤活性的间双四氢呋喃型番荔枝内酯类化合物及其制备方法与应用 |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1073999A (en) * | 1965-01-29 | 1967-06-28 | Ncr Co | Process for forming stable images in photochromic material |
EP0169375B1 (fr) | 1984-06-23 | 1989-12-20 | Nissan Chemical Industries Ltd. | Procédé de préparation de 2-tertio-butyl-4,5-dichloro-3(2H)-pyridazinone |
US5393512A (en) | 1985-01-14 | 1995-02-28 | Vanderheyden; Jean-Luc | Stable therapeutic radionuclide compositions and methods for preparation thereof |
AU6621586A (en) * | 1985-11-18 | 1987-06-02 | University Of Texas System, The | Polychelating agents for image and spectral enhancement (and spectral shift) |
JPS6315974A (ja) | 1986-07-09 | 1988-01-23 | 小泉コンピユ−タ−株式会社 | ボ−リングゲ−ム点数表表示装置 |
US5252317A (en) * | 1986-11-10 | 1993-10-12 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
US5567411A (en) * | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
IT1229684B (it) | 1989-04-05 | 1991-09-06 | Mini Ricerca Scient Tecnolog | Piridazinoni ad attivita' insetticida ed acaricida |
US5087440A (en) * | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
GB8923843D0 (en) * | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
US5377681A (en) | 1989-11-13 | 1995-01-03 | University Of Florida | Method of diagnosing impaired blood flow |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5228446A (en) * | 1989-12-22 | 1993-07-20 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
US5088499A (en) * | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5679810A (en) * | 1990-01-19 | 1997-10-21 | Salutar, Inc. | Linear oligomeric polychelant compounds |
WO1992017215A1 (fr) | 1990-03-28 | 1992-10-15 | Nycomed Salutar, Inc. | Milieux de contraste |
GB9006977D0 (en) | 1990-03-28 | 1990-05-23 | Nycomed As | Compositions |
US5205290A (en) * | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5306482A (en) | 1991-04-09 | 1994-04-26 | Merck Frosst Canada, Inc. | Radiopharmaceutical bacteriostats |
US5093105A (en) | 1991-04-09 | 1992-03-03 | Merck Frosst Canada, Inc. | Radiopharmaceutical bacteriostats |
JP3853354B2 (ja) | 1991-08-29 | 2006-12-06 | マリンクロッド・インコーポレイテッド | 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤 |
US5169942A (en) | 1991-11-21 | 1992-12-08 | General Electric Company | Method for making 2-(18F)fluoro-2-deoxy-D-glucose |
US5760191A (en) * | 1993-02-05 | 1998-06-02 | Nycomed Imaging As | Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
WO1994021653A1 (fr) | 1993-03-22 | 1994-09-29 | General Electric Company | Procede pour fabriquer le 2-fluoro-2-desoxyglucose |
AU6493894A (en) | 1993-03-31 | 1994-10-24 | Mallinckrodt Medical, Inc. | Radiopharmaceutical formulations having non-stannous reductants |
US5417959A (en) * | 1993-10-04 | 1995-05-23 | Mallinckrodt Medical, Inc. | Functionalized aza-crytand ligands for diagnostic imaging applications |
BR9408590A (pt) | 1994-06-03 | 1997-08-26 | Malinckrodt Medical Inc | Agentes para imageamento ósseo rapidamente eliminaveis de fosfonato de tecnécio 99m |
US5520904A (en) * | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
EP0727225A3 (fr) | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions et méthodes pour l'imagerie ultrasonique dirigée |
US5587491A (en) | 1995-03-15 | 1996-12-24 | Regents Of The University Of Minnesota | Method for the synthesis of bis-tetrahydrofuranyl Annonaceous acetogenins |
US5801228A (en) * | 1995-06-07 | 1998-09-01 | Nycomed Imaging As | Polymeric contrast agents for medical imaging |
US6066309A (en) | 1996-02-02 | 2000-05-23 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
US5804161A (en) * | 1996-05-14 | 1998-09-08 | Nycomed Salutar Inc. | Contrast agents |
US5846517A (en) * | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
US5677467A (en) | 1996-10-03 | 1997-10-14 | Regents Of The University Of Minnesota | Synthesis of acetogenins |
US6565889B2 (en) * | 1996-12-02 | 2003-05-20 | The Regents Of The University Of California | Bilayer structure which encapsulates multiple containment units and uses thereof |
US5961955A (en) | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
US6056939A (en) | 1998-08-28 | 2000-05-02 | Desreux; Jean F. | Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals |
ATE439838T1 (de) | 1998-09-29 | 2009-09-15 | Merck & Co Inc | Radiomarkierte neurokinin-1 rezeptor antagonisten |
US6645508B1 (en) | 1999-06-18 | 2003-11-11 | Jivn-Ren Chen | Stable L-ascorbic acid composition |
WO2002020008A1 (fr) | 2000-09-06 | 2002-03-14 | The Scripps Research Institute | Oxidoreductase d'ubiquinone utilisee comme inhibiteur de nadh |
TWI247609B (en) | 2001-01-23 | 2006-01-21 | Nihon Mediphysics Co Ltd | Agent for diagnosis of tissue proliferation activity or the treatment of proliferative disease |
GB0115927D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
US20030044354A1 (en) * | 2001-08-16 | 2003-03-06 | Carpenter Alan P. | Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release |
CA2463579A1 (fr) | 2001-10-16 | 2003-04-24 | Hypnion, Inc. | Traitement de troubles du systeme nerveux central (snc) a l'aide de modulateurs de cible snc |
NZ534496A (en) | 2002-02-06 | 2006-08-31 | Univ Johns Hopkins | Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
NZ535438A (en) | 2002-03-29 | 2006-08-31 | Janssen Pharmaceutica Nv | Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
AU2003224747A1 (en) | 2002-04-08 | 2003-10-27 | Biostream, Inc. | Technetium-labeled rotenone derivatives, and methods of use thereof |
GB0229683D0 (en) | 2002-12-20 | 2003-01-29 | Imaging Res Solutions Ltd | Preparation of radiopharmaceuticals |
GB0317920D0 (en) | 2003-07-31 | 2003-09-03 | Amersham Plc | Solid-phase synthesis |
US7485283B2 (en) | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
US20060083681A1 (en) | 2004-10-18 | 2006-04-20 | Ajay Purohit | Compounds for myocardial perfusion imaging |
KR100789847B1 (ko) | 2004-12-15 | 2007-12-28 | (주)퓨쳐켐 | 알코올 용매하에서 유기플루오로 화합물의 제조방법 |
CA2612186A1 (fr) | 2005-06-23 | 2007-01-04 | Emory University | Agents pour l'imagerie |
US7824659B2 (en) | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
JP5916039B2 (ja) | 2006-06-21 | 2016-05-11 | ジーイー・ヘルスケア・リミテッド | 放射性医薬品製品 |
GB0718386D0 (en) | 2007-09-21 | 2007-10-31 | Ge Healthcare As | Improved radiopharmaceutical formulation |
CA2967254C (fr) | 2008-02-29 | 2019-03-26 | Lantheus Medical Imaging, Inc. | Agents de contraste destine aux applications comprenant l'imagerie du cancer |
CN101555232B (zh) | 2009-05-21 | 2011-01-05 | 北京师范大学 | 氟-18标记哒嗪酮类化合物及制备方法和应用 |
JP6092628B2 (ja) | 2010-02-08 | 2017-03-08 | ランセウス メディカル イメージング, インコーポレイテッド | 造影剤およびその中間体を合成するための方法および装置 |
-
2005
- 2005-04-25 US US11/113,486 patent/US7485283B2/en active Active
- 2005-04-27 EP EP10176056.9A patent/EP2253333B1/fr active Active
- 2005-04-27 SG SG200902714-5A patent/SG152254A1/en unknown
- 2005-04-27 JP JP2007510933A patent/JP2007535547A/ja active Pending
- 2005-04-27 AU AU2005238080A patent/AU2005238080B2/en active Active
- 2005-04-27 WO PCT/US2005/014459 patent/WO2005105159A2/fr active Application Filing
- 2005-04-27 EP EP05756378A patent/EP1740225A4/fr not_active Withdrawn
- 2005-04-27 CN CN201010193657.6A patent/CN101843908B/zh active Active
- 2005-04-27 RU RU2006141979/04A patent/RU2006141979A/ru unknown
- 2005-04-27 MX MXPA06012299A patent/MXPA06012299A/es not_active Application Discontinuation
- 2005-04-27 BR BRPI0510487-4A patent/BRPI0510487A/pt not_active Application Discontinuation
- 2005-04-27 CA CA2564737A patent/CA2564737C/fr active Active
- 2005-04-27 ES ES10176056T patent/ES2744544T3/es active Active
-
2006
- 2006-10-27 KR KR1020067022493A patent/KR101207216B1/ko active IP Right Grant
- 2006-10-29 IL IL178911A patent/IL178911A/en active IP Right Grant
- 2006-11-03 NO NO20065048A patent/NO20065048L/no not_active Application Discontinuation
-
2008
- 2008-12-19 US US12/339,694 patent/US8263042B2/en active Active
-
2012
- 2012-08-10 US US13/571,911 patent/US20130028837A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1740225A2 (fr) | 2007-01-10 |
IL178911A0 (en) | 2007-03-08 |
CN101843908B (zh) | 2014-09-10 |
EP2253333B1 (fr) | 2019-06-12 |
AU2005238080B2 (en) | 2011-02-10 |
US7485283B2 (en) | 2009-02-03 |
CA2564737A1 (fr) | 2005-11-10 |
IL178911A (en) | 2013-10-31 |
CN101843908A (zh) | 2010-09-29 |
JP2007535547A (ja) | 2007-12-06 |
EP2253333A2 (fr) | 2010-11-24 |
KR20070007859A (ko) | 2007-01-16 |
MXPA06012299A (es) | 2006-12-15 |
ES2744544T3 (es) | 2020-02-25 |
EP1740225A4 (fr) | 2009-08-19 |
BRPI0510487A (pt) | 2007-11-13 |
US20090104118A1 (en) | 2009-04-23 |
CA2564737C (fr) | 2014-03-18 |
US20130028837A1 (en) | 2013-01-31 |
US20050244332A1 (en) | 2005-11-03 |
EP2253333A3 (fr) | 2013-05-08 |
AU2005238080A1 (en) | 2005-11-10 |
US8263042B2 (en) | 2012-09-11 |
WO2005105159A3 (fr) | 2006-04-27 |
SG152254A1 (en) | 2009-05-29 |
WO2005105159A2 (fr) | 2005-11-10 |
KR101207216B1 (ko) | 2012-12-03 |
RU2006141979A (ru) | 2008-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065048L (no) | Kontrastmidler for myocardial perfusjonsbilleddannelse. | |
NO20064011L (no) | Kontrastmidler for myokardial perfusjonsbilleddannelse | |
WO2009110984A3 (fr) | Agents de contraste pour des applications comprenant une imagerie de perfusion | |
CR10091A (es) | Compuestos orgánicos | |
BRPI0416628A (pt) | uso de compostos orgánicos | |
BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
LTPA2016032I1 (lt) | Hipoglikeminių agentų skyrimo būdai | |
NO20074295L (no) | Substituerte gamma lactamer som terapeutiske midler | |
BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
EA200100934A1 (ru) | Применение ингибиторов cyp2d6 в комбинированных способах лечения | |
NO20071791L (no) | Preparater og fremgangsmater for diagnostiseringen og behandlingen av tumor | |
RS52110B (en) | DIPEPTIDIL PEPTIDASE INHIBITORS FOR TREATMENT OF DIABETES | |
UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
EA200301215A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
BRPI0605921B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
NO20082837L (no) | Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner | |
AR058085A1 (es) | Sal de dihidrogeno fosfato de un antagonista del receptor de prostaglandina d2. composiciones farmaceuticas. | |
AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
NO20084821L (no) | Formuleringer og metoder for celleimaging og terapi | |
BRPI0714885B8 (pt) | compostos terapêuticos e seu uso | |
NO20076241L (no) | Terapier for vaskulaere sykdommer | |
MX2007004277A (es) | Compuestos para la produccion de imagenes por perfusion miocardial. | |
UY29069A1 (es) | Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia | |
RU2008130043A (ru) | Комбинация, включающая комбретастатин и противораковые средства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |